Home » Archive

Marketwire

Marketwire, News, Syndication »

Medistem Receives Notice of Patent Allowance Covering Fat Stem Cell Therapy of Autoimmune Diseases

Posted by Mary Canady June 28th, 2012 .
No Comments

SAN DIEGO CA–(Marketwire – Jun 29, 2012) –  Medistem Inc. (PINKSHEETS: MEDS) announced today notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent covering the use of fat stem cells, and cells associated with f…

More...

Marketwire, News, Syndication »

Genelux Corporation Announces Ground-Breaking Clinical Study Evaluating Oncolytic Vaccinia Virus in Canine Cancer Patients

Posted by Mary Canady June 28th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 28, 2012) – Genelux Corporation, a clinical-stage biopharmaceutical company developing vaccinia virus-based oncolytic (cancer-killing) therapies and companion diagnostics for cancer, today announced the start of a gr…

More...

Marketwire, News, Syndication »

Bio-Matrix Scientific Group, Inc. Recruits Senior Scientist for Its Regen BioPharma Subsidiary

Posted by Mary Canady June 26th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 26, 2012) – Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN) announced today Thomas E. Ichim, PhD has joined the management team of its Regen BioPharma, Inc. subsidiary as Chief Scientific Officer a…

More...

Marketwire, News, Syndication »

Bio-Matrix Scientific Group, Inc. Recruits Senior Scientist for Its Regen BioPharma Subsidiary

Posted by Mary Canady June 26th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 26, 2012) – Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN) announced today Thomas E. Ichim, PhD has joined the management team of its Regen BioPharma, Inc. subsidiary as Chief Scientific Officer a…

More...

Marketwire, News, Syndication »

AstraZeneca Completes Acquisition of Ardea Biosciences

Posted by Mary Canady June 20th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 20, 2012) – AstraZeneca today announced that on Tuesday, June 19, 2012 it completed its acquisition of San Diego, California-based biotechnology company Ardea Biosciences, Inc. The merger was approved by Ardea’s stoc…

More...

Marketwire, News, Syndication »

Bio-Matrix Scientific Group Announces David Audley, the Founder of International Cellular Medicine Society, Has Joined the Advisory Board of Its Regen BioPharma Subsidiary

Posted by Mary Canady June 15th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 15, 2012) – Bio-Matrix Scientific Group (OTCQB: BMSN) (PINKSHEETS: BMSN) announced today the appointment of David Audley to the advisory board of Its Regen BioPharma subsidiary. Mr. Audley will advise Regen BioPharma…

More...

Marketwire, News, Syndication »

Genelux Corporation Announces First Patient Dosed in Phase I Combination Clinical Trial of GL-ONC1

Posted by Mary Canady June 14th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 14, 2012) – Genelux Corporation, a clinical-stage biopharmaceutical company developing vaccinia virus-based oncolytic (cancer-killing) therapies and companion diagnostics for cancer, today announced that the first pa…

More...

Marketwire, News, Syndication »

Full Spectrum Genetics and BioBlocks Enter Collaboration to Discover Novel Small Molecule Therapeutics That Inhibit a Commercially Validated Cancer Target

Posted by Mary Canady June 13th, 2012 .
No Comments

SOUTH SAN FRANCISCO, CA and SAN DIEGO, CA–(Marketwire – Jun 13, 2012) – Full Spectrum Genetics, Inc., a privately-held biopharmaceutical company, and BioBlocks, Inc., a privately-held small molecule lead discovery company today announced entering a…

More...

Marketwire, News, Syndication »

SG Biofuels Opens Expanded Headquarters & Genomics Research Center to Support Commercial Advancements

Posted by Mary Canady June 12th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 12, 2012) – SG Biofuels, Inc. (SGB), an energy crop company delivering high performance bioenergy solutions for the renewable fuel, biomass and chemical markets, has opened an expanded corporate headquarters and geno…

More...

Marketwire, News, Syndication »

Bio-Matrix Scientific Group’s Regen BioPharma Subsidiary Executes Option Agreement to License Stem Cell Intellectual Property

Posted by Mary Canady June 7th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 7, 2012) – Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN) announced today that its wholly owned subsidiary Regen BioPharma, Inc. has executed an exclusive option agreement which grants Regen BioPh…

More...